<\/p>\n
Lovegra Oral Jelly 100 mg (oral jelly sachet)<\/strong> con\u021bine citrat de sildenafil<\/strong> ca tablet\u0103 oral\u0103 de la Ajanta Pharma, comercializat\u0103 pentru dificult\u0103\u021bi de excita\u021bie sexual\u0103 \u0219i lubrifiere la femei<\/strong>. Not\u0103 reglementar\u0103 important\u0103:<\/strong> sildenafilul NU este aprobat de FDA pentru nicio indica\u021bie feminin\u0103<\/strong>. Utilizarea la femei este off-label<\/strong>. Medicamentele aprobate de FDA pentru tulburarea hipoactiv\u0103 a dorin\u021bei sexuale la femei (HSDD) \u0219i tulburarea excita\u021biei sexuale feminine (FSAD) sunt flibanserin (Addyi)<\/strong> \u0219i bremelanotide (Vyleesi)<\/strong>, care ac\u021bioneaz\u0103 prin mecanisme diferite. Dovezile pentru sildenafil la femei sunt mixte<\/strong>: beneficii modeste pentru disfunc\u021bia sexual\u0103 indus\u0103 de SSRI la femei, beneficii limitate pentru FSAD general \u0219i unele beneficii pentru excita\u021bie\/lubrifia\u021bie la femeile perimenopauzale f\u0103r\u0103 dorin\u021b\u0103 sc\u0103zut\u0103. Typical dose (off-label): 50-100 mg approximately 15-30 minutes before anticipated sexual activity (jelly — partial buccal absorption).<\/strong> Contraindica\u021biile sunt similare cu cele ale sildenafilului masculin: evita\u021bi absolut cu nitra\u021bi sau stimulatoare de guanilat ciclaz\u0103, precau\u021bie \u00een caz de boli cardiovasculare, insuficien\u021b\u0103 hepatic\u0103\/renal\u0103. Efecte secundare comune: cefalee, ro\u0219ea\u021b\u0103 facial\u0103, congestie nazal\u0103, dispepsie u\u0219oar\u0103.<\/p>\n<\/div>\n \ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n Lovegra Oral Jelly<\/strong> delivers sildenafil 100 mg in a single-use sachet form that is squeezed onto the tongue, dissolved briefly in the mouth, and swallowed — no water needed. Advantages over a swallow-whole tablet for this female-marketed use:<\/p>\n The active ingredient and dose are identical to swallow-whole sildenafil 100 mg (e.g. Lovegra<\/a> sau Ladygra<\/a> tablets). All contraindications, interactions and off-label \/ FDA-not-approved regulatory framing are the same.<\/p>\n Lovegra Oral Jelly is an oral sildenafil citrate 100 mg (oral jelly sachet)<\/strong> comprimat de Ajanta Pharma<\/strong>, supplied in packs of 7 \/ 28 \/ 49 \/ 70 \/ 98 sachets. Lovegra Oral Jelly is Ajanta Pharma’s sildenafil 100 mg de jeleu oral pentru o singur\u0103 folosin\u021b\u0103<\/strong> marketed for female sexual arousal difficulties. Combines the female-labelled positioning of Lovegra tablets with the faster-onset, water-free convenience of the oral jelly format — each sachet is squeezed onto the tongue and swallowed.<\/p>\n Sildenafilul este un inhibitor al fosfodiesterazei de tip 5 (PDE5)<\/strong> cel mai cunoscut sub numele s\u0103u de marc\u0103 original Viagra\u00ae<\/strong> (Pfizer, FDA-approved 1998 for male erectile dysfunction). The FDA has never approved sildenafil for any female indication. Nonetheless, sildenafil has been studied off-label in women for more than two decades, and some specialist clinicians prescribe it off-label for specific subsets of female sexual dysfunction. Lovegra Oral Jelly is marketed internationally for that off-label female-sexual-health use.<\/p>\n Acestea NU fac parte din aceea\u0219i clas\u0103 cu sildenafilul. Dac\u0103 problema ta principal\u0103 este libid\u0103 sc\u0103zut\u0103<\/strong>, flibanserin sau bremelanotid\u0103 au \u0219anse mai mari s\u0103 ajute dec\u00e2t sildenafil. Dac\u0103 principala ta problem\u0103 este excitare sau lubrifiere<\/strong> (cu libid\u0103 intact\u0103), unii clinici speciali\u0219ti prescriu sildenafil off-label pe baza unor studii mici. Vorbe\u0219te cu un clinician cu experien\u021b\u0103 \u00een disfunc\u021biile sexuale feminine \u00eenainte de a te auto-trata.<\/div>\n R\u0103spunsul de excitare genital\u0103 feminin\u0103 \u00eemp\u0103rt\u0103\u0219e\u0219te mare parte din fiziologia sa cu r\u0103spunsul erectil masculin:<\/p>\n Deoarece densitatea PDE5 este mai mic\u0103 \u00een \u021besutul genital feminin dec\u00e2t \u00een corpul cavernos masculin, amploarea efectului este de obicei mai mic\u0103 la femei dec\u00e2t la b\u0103rba\u021bi la doze echivalente<\/strong>. \u00centrebarea clinic\u0103 este dac\u0103 efectul farmacologic modest se traduce \u00eentr-o \u00eembun\u0103t\u0103\u021bire subiectiv\u0103 semnificativ\u0103, iar r\u0103spunsul depinde \u00een mare m\u0103sur\u0103 de subtipul specific de disfunc\u021bie sexual\u0103 feminin\u0103.<\/p>\n Sildenafilul la femei a fost studiat \u00een mai multe subpopula\u021bii specifice cu rezultate diferite:<\/p>\n Concluzie:<\/strong> sildenafilul este un vasodilatator genital periferic. Poate ajuta femeile al c\u0103ror r\u0103spuns de excita\u021bie periferic\u0103 este diminuat (de ex., la pacien\u021bii care iau SSRI). Nu abordeaz\u0103 dorin\u021ba sc\u0103zut\u0103, factorii rela\u021bionali sau deficitele de excita\u021bie central\u0103. Evaluarea corespunz\u0103toare cu un clinician experimentat \u00een disfunc\u021biile sexuale feminine este primul pas corect.<\/p>\n V\u00e2rstnici (>65 de ani):<\/strong> se poate \u00eencepe cu 25 mg. Insuficien\u021b\u0103 hepatic\u0103 sever\u0103:<\/strong> reduce\u021bi la 25 mg. Insuficien\u021b\u0103 renal\u0103 sever\u0103 (eGFR <30):<\/strong> reduce\u021bi la 25 mg. Inhibitor puternic CYP3A4 concomitent<\/strong> (ketoconazol, ritonavir, claritromicin\u0103): \u00eencepe\u021bi cu 25 mg.<\/p>\n Sarcin\u0103 \u0219i al\u0103ptare:<\/strong> Categoria de sarcin\u0103 B (date animale reasigur\u0103toare, date umane limitate). De obicei evitat \u00een timpul sarcinii \u0219i al\u0103pt\u0103rii \u00een afara indica\u021biilor specializate (sildenafilul este utilizat \u00een hipertensiunea pulmonar\u0103 pediatric\u0103 la nou-n\u0103scu\u021bi, inclusiv \u00een timpul sarcinii pentru unele afec\u021biuni fetale, sub \u00eendrumare specializat\u0103).<\/p>\nDe ce s\u0103 comanzi de la MedsBase<\/h3>\n
De ce jeleu oral \u00een loc de tablet\u0103?<\/h2>\n
\n
What Is Lovegra Oral Jelly?<\/h2>\n
Sildenafilul NU este aprobat de FDA pentru disfunc\u021bia sexual\u0103 feminin\u0103<\/strong>. Medicamentele aprobate de FDA pentru tulburarea de dorin\u021b\u0103 sexual\u0103 hipoactiv\u0103 (HSDD) la femeile premenopauzale sunt:<\/p>\n\n
Cum Ac\u021bioneaz\u0103 Sildenafilul la Femei?<\/h2>\n
\n
Cine poate beneficia \u2014 \u0219i cine este pu\u021bin probabil s\u0103 beneficieze<\/h2>\n
\n
Lovegra Oral Jelly Dose and How to Take<\/h2>\n
\n
Efecte Secundare<\/h2>\n
Frecvente<\/h3>\n
\n
Mai pu\u021bin frecvente \/ rare<\/h3>\n
\n
Rare, dar grave \u2014 c\u0103uta\u021bi imediat ajutor medical<\/h3>\n
\n
Contraindica\u021bii \u0219i avertismente<\/h2>\n
\n
Interac\u021biuni medicamentoase<\/h2>\n